Eosinophilic enteropathy clinical trials

The registry lists 28 studies for Eosinophilic enteropathy across more than 10 countries. 5 are recruiting or about to start. 16 of them are mainly about Eosinophilic enteropathy (how this is decided). Per ClinicalTrials.gov, last updated 2026-10-28.

Get an email when these change. Save the Eosinophilic enteropathy studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies

See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Status

Completed: 16
Recruiting: 5
Terminated: 4
Withdrawn: 2
Active, not recruiting: 1

Phase

Phase 2: 7
Phase 3: 7
Phase 1: 2
Phase 4: 1

Where

United States: 26
Japan: 3
Italy: 3
Poland: 1
Brazil: 1
Vietnam: 1

Who runs them

Children's Hospital Medical Center, Cincinnati (8) · Allakos Inc. (6) · National Institute of Allergy and Infectious Diseases (NIAID) (4) · Regeneron Pharmaceuticals (1) · Sanford Health (1) · Ann & Robert H Lurie Children's Hospital of Chicago (1) · Celgene (1) · Marc Rothenberg (1)

What is being tested here

Drugs under test in Eosinophilic enteropathy studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

Drug	Phase 3	All
AK002	4	6
Dupilumab	0	2
Benralizumab	2	2
Cendakimab	1	1
Ondansetron	0	1
Mepolizumab	0	1
Omalizumab	0	1
Montelukast	0	1
Sirolimus	0	1

Coming up

0phase 3 studies under way

1study finishes main data collection within a year

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

The study

Jan 2027National, Multicenter, Retrospective, Prospective Study to Evaluate Pediatric Gastrointestinal Eosinophilic Disorders · Fondazione IRCCS Policlinico San Matteo di Pavia

Who these studies take

Of the 5 Eosinophilic enteropathy studies recruiting now, 2 (40%) set no upper age limit and 3 (60%) stop at 75 or younger. 4 (80%) take children under 18. 0 (0%) are for women only and 0 (0%) for men only; 0 (0%) take healthy volunteers.

Recruiting studies that take each age, of 5
Age	Women	Men
10	4 (80%)	4 (80%)
18	5 (100%)	5 (100%)
30	3 (60%)	3 (60%)
40	3 (60%)	3 (60%)
50	3 (60%)	3 (60%)
65	2 (40%)	2 (40%)
75	2 (40%)	2 (40%)
85	2 (40%)	2 (40%)

Across all 28 studies, recruiting or not: 50% stop at 75 or younger and 43% at 65; 61% take children; 0% are for women only and 0% for men only; 11% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

Studies

Recruiting first, then most recently updated. Showing 28 of 28. search them.